End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
138 SAR | +3.76% | +6.32% | +20.00% |
Apr. 04 | Jamjoom Pharmaceuticals Factory Declares Second Interim Dividend for FY23 | MT |
Mar. 25 | Jamjoom Pharmaceuticals Factory Posts Higher FY23 Profit, Revenue | MT |
Sales 2024 * | 1.27B 340M | Sales 2025 * | 1.46B 388M | Capitalization | 9.66B 2.58B |
---|---|---|---|---|---|
Net income 2024 * | 312M 83.26M | Net income 2025 * | 381M 102M | EV / Sales 2024 * | 7.34 x |
Net cash position 2024 * | 306M 81.7M | Net cash position 2025 * | 415M 111M | EV / Sales 2025 * | 6.35 x |
P/E ratio 2024 * |
30.9
x | P/E ratio 2025 * |
25.3
x | Employees | - |
Yield 2024 * |
2.13% | Yield 2025 * |
2.43% | Free-Float | 30% |
1 day | +3.76% | ||
1 week | +6.32% | ||
Current month | +6.32% | ||
1 month | +4.55% | ||
3 months | -3.09% | ||
6 months | +25.23% | ||
Current year | +20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Tarek Hosni
CEO | Chief Executive Officer | 60 | 21-05-14 |
Anwer Muhiddein
DFI | Director of Finance/CFO | 60 | 13-01-12 |
Mohammed Jamjoom
COO | Chief Operating Officer | 29 | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faris AlGhannam
BRD | Director/Board Member | - | 22-06-18 |
Chairman | 64 | 22-06-18 | |
Founder | 39 | 22-06-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 138 | +3.76% | 698,065 |
24-05-06 | 133 | +0.76% | 172,722 |
24-05-05 | 132 | -0.60% | 92,025 |
24-05-02 | 132.8 | -0.15% | 185,975 |
24-05-01 | 133 | +2.47% | 216,200 |
End-of-day quote Saudi Arabian S.E., May 06, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.00% | 2.58B | |
+20.65% | 43.57B | |
+20.70% | 22.7B | |
+11.68% | 14.32B | |
+11.64% | 13.42B | |
+45.24% | 11.83B | |
-8.84% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.51B |
- Stock Market
- Equities
- 4015 Stock